Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems,…
3 analysts rate BCPC Buy on consensus.
Consensus price target: $209.25 (+20.79% upside from $173.23)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| van Gunsteren Job Leonard SVP and GM, Specialty Products | Dec 4, 2025 | Sale | 1,765 | $271.46K |
| van Gunsteren Job Leonard SVP and GM, Specialty Products | Dec 4, 2025 | Sale | 4,235 | $648.26K |
| Fischer David B director | Dec 3, 2025 | Sale | 2,000 | $308.29K |
| Fischer David B director | Dec 3, 2025 | Sale | 6,000 | $923.46K |
| Reid Martin Luther SVP Chief Supply Chain Officer | Nov 11, 2025 | Sale | 1,200 | $185.33K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $1.04B | +8.75% | $154.85M |
| 2024 | $953.68M | +3.39% | $128.48M |
| 2023 | $922.44M | -2.11% | $108.54M |
Stock data for BCPC: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics